Jaguar Animal Health Statistics
Jaguar Animal Health (1JA2) Stock Statistics & Valuation Metrics
Total Valuation
Jaguar Animal Health has a market cap or net worth of EUR 836.99K. The enterprise value is EUR 12.45M.
- Market Cap
- EUR 836.99K
- Enterprise Value
- EUR 12.45M
Share Statistics
Jaguar Animal Health has 2,323,373 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 2,323,373
- Owned by Insiders
- 4.48%
- Owned by Institutions
- 1.08%
Financial Efficiency
Jaguar Animal Health’s return on equity (ROE) is 3.09 and return on invested capital (ROIC) is -178.29%.
- Return on Equity (ROE)
- 3.09
- Return on Assets (ROA)
- -1.39
- Return on Invested Capital (ROIC)
- -178.29%
- Return on Capital Employed (ROCE)
- 19.35
- Revenue Per Employee
- 244.91K
- Profits Per Employee
- -1.14M
- Employee Count
- 47
- Asset Turnover
- 0.30
- Inventory Turnover
- 0.44
Valuation Ratios
The current PE Ratio of Jaguar Animal Health is -0.00. Jaguar Animal Health’s PEG ratio is -0.00.
- PE Ratio
- -0.00
- PS Ratio
- 0.04
- PB Ratio
- 0.00
- Price to FCF
- -0.15
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Jaguar Animal Health had revenue of 11.51M and earned -53.43M in profits. Earnings per share was -12059.25.
- Revenue
- 11.51M
- Gross Profit
- 7.74M
- Operating Income
- -45.11M
- Pretax Income
- -54.00M
- Net Income
- -53.43M
- EBITDA
- -51.73M
- Earnings Per Share (EPS)
- -12059.25
Cash Flow
In the last 12 months, operating cash flow was -6.74M and capital expenditures -25,000, giving a free cash flow of -6.76M billion.
- Operating Cash Flow
- -6.74M
- Free Cash Flow
- -6.76M
- Free Cash Flow per Share
- -125.40
Dividends & Yields
Jaguar Animal Health pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -677.20%
- Earnings Yield
- -158038.84%
Stock Price Statistics
- Beta
- -0.07
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 99225.00
- 200-Day Moving Average
- 99225.00
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Jaguar Animal Health upcoming earnings date is Nov 18, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 19, 2026
- Next Earnings Date
- Nov 18, 2026
- Ex-Dividend Date
- ―
Financial Position
Jaguar Animal Health as a current ratio of 0.50, with Debt / Equity ratio of -252.22%
- Current Ratio
- 0.50
- Quick Ratio
- 0.29
- Debt to Market Cap
- 19.58
- Net Debt to EBITDA
- -0.82
- Interest Coverage Ratio
- 673.25
Taxes
In the past 12 months, Jaguar Animal Health has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Jaguar Animal Health EV to EBITDA ratio is -0.28, with an EV/FCF ratio of -1.64.
- EV to Sales
- 0.40
- EV to EBITDA
- -0.28
- EV to Free Cash Flow
- -1.64
- EV to Operating Cash Flow
- -1.64
Balance Sheet
Jaguar Animal Health has EUR 6.59M in cash and marketable securities with EUR 16.65M in debt, giving a net cash position of -EUR 10.06M billion.
- Cash & Marketable Securities
- EUR 6.59M
- Total Debt
- EUR 16.65M
- Net Cash
- -EUR 10.06M
- Net Cash Per Share
- -EUR 4.33
- Tangible Book Value Per Share
- -EUR 188.45
Margins
Gross margin is 82.31%, with operating margin of -90.22%, and net profit margin of -131.76%.
- Gross Margin
- 82.31%
- Operating Margin
- -90.22%
- Pretax Margin
- -132.73%
- Net Profit Margin
- -131.76%
- EBITDA Margin
- -143.70%
- EBIT Margin
- -151.47%
Analyst Forecast
The average price target for Jaguar Animal Health is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 119.33%
- EPS Growth Forecast
- 86.53%
